GILEAD SCIENCES, INC. — Director's Dealing 2018

Jan 4, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2018-01-02

Reporting Person: Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-02	Common Stock	M	8625	$24.905	Acquired	64613	Direct
2018-01-02	Common Stock	S	8625	$74.00	Disposed	55988	Direct
2018-01-02	Common Stock	S	700	$72.3371	Disposed	55288	Direct
2018-01-02	Common Stock	S	5675	$73.8561	Disposed	49613	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-01-02	Non-qualified Stock Option (Right to Buy)	$24.905	M	8625	Disposed	2019-07-29	Common Stock (8625)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.

F3: Sale prices reported for the transactions reported here range from $71.88 to $72.87. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F4: Sale prices reported for the transactions reported here range from $73.37 to $74.24. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.